Sage Therapeutics Stock Soars 36% After Sale to Supernus Pharmaceuticals. What We Know.
Latest News
- 10 Life Insurance Myths That Could Be Costing You
- JPMorgan studied 5 million US retirees — and named 3 spending trends you need to factor into your plan
- What’s Behind PayPal’s Will Ferrell Ads?
- Pharma manufacturing 'boom' faces high costs, potential delays
- Follow the Flows: Why Some Legacy Mutual Fund Firms Are Finally Exploring ETFs
- Analyst Report: Rio Tinto PLC